These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9084778)

  • 21. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical shift misregistration artifact: increased conspicuity following intravenous administration of gadopentetate dimeglumine.
    Apicella PL; Mirowitz SA; Borrello JA
    Magn Reson Imaging; 1994; 12(4):675-8. PubMed ID: 8057773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
    Strouse PJ; Prince MR; Chenevert TL
    Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
    Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP
    Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
    Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
    Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
    Goldstein HA; Kashanian FK; Blumetti RF; Holyoak WL; Hugo FP; Blumenfield DM
    Radiology; 1990 Jan; 174(1):17-23. PubMed ID: 2403679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
    Witte RJ; Anzai LL
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An experimental study on the neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia.
    La Noce A; Miragoli L; Samuelli G; Tirone P
    Invest Radiol; 1996 Sep; 31(9):550-5. PubMed ID: 8877491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of joint fluid with intravenously administered gadopentetate dimeglumine: technique, rationale, and implications.
    Winalski CS; Aliabadi P; Wright RJ; Shortkroff S; Sledge CB; Weissman BN
    Radiology; 1993 Apr; 187(1):179-85. PubMed ID: 8451409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects caused by rapid administration of gadoversetamide injection in anesthetized dogs.
    Wible JH; Galen KP; Wojdyla JK
    Invest Radiol; 2001 May; 36(5):292-8. PubMed ID: 11394361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local tissue toxicity in response to extravascular extravasation of magnetic resonance contrast media.
    Runge VM; Dickey KM; Williams NM; Peng X
    Invest Radiol; 2002 Jul; 37(7):393-8. PubMed ID: 12068161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of Gd-dimeglumine on subcutaneous tissues: a study with rats.
    McAlister WH; McAlister VI; Kissane JM
    AJNR Am J Neuroradiol; 1990; 11(2):325-7. PubMed ID: 2107714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G; Rinck PA; Børseth A
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging detection of extraluminal enterally administered gadopentetate dimeglumine in a rat model of intestinal ischemia.
    Montalbano JM; Lee FT; Grist TM; Rappe AH; Weiss JW; Kelcz F; Gribenko V
    Acad Radiol; 1996 Jun; 3(6):486-92. PubMed ID: 8796706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S; Hoffman JC
    AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings.
    Roman-Goldstein SM; Barnett PA; McCormick CI; Szumowski J; Shannon EM; Ramsey FL; Mass M; Neuwelt EA
    J Comput Assist Tomogr; 1994; 18(5):731-6. PubMed ID: 8089321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bolus injection of MR contrast agents: hemodynamic effects evaluated by intracerebral laser Doppler flowmetry in rats.
    Doerfler A; Forsting M; Reith W; Heiland S; Weber J; Hacke W; Sartor K
    AJNR Am J Neuroradiol; 1997 Mar; 18(3):427-34. PubMed ID: 9090398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
    Lundby B; Gordon P; Hugo F
    Eur J Radiol; 1996 Nov; 23(3):190-6. PubMed ID: 9003923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW; Chang KH; Choi DS; Han MH; Han MC
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.